SQSTM1 and Alzheimer disease: The p62 concentrations were found to be significantly different between AD patients and controls (0.74 ± 0.64 ng/mL vs. 0.15 ± 0.33 ng/mL, p = 0.011) (Figure 1), which persisted after adjusting for age (p = 0.01).